A synthetically produced agent with the same properties as LUTEINISING HORMONERELEASING HORMONE (LHRH).
see gonadorelin analogue.
n. a drug that differs in minor ways in molecular structure from its parent compound. Examples are *calcipotriol (an analogue of vitamin D), *betahistine (an analogue of histamine), and the *gonadorelin analogues. Useful analogues of existing drugs are either more potent or cause fewer side-effects. *Carboplatin and *oxaliplatin, for example, are less toxic analogues of *cisplatin.... analogue
(GnRH analogue, LHRH analogue) any one of a group of analogues of *gonadotrophin-releasing hormone (gonadorelin), which stimulates release of the gonadotrophins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. They are more powerful than the naturally occurring hormone, initially increasing the secretion of gonadotrophins by the pituitary: this acts to block the hormone receptors and to inhibit the release of further gonadotrophins, which suppresses production of oestrogens and androgens. Gonadorelin analogues include *buserelin, *goserelin, leuprorelin, and triptorelin. They are used in the treatment of endometriosis, fibroids, and some types of infertility. GnRH analogues are also used in the treatment of advanced prostate cancer. After causing an initial rise in plasma testosterone for approximately ten days the level then falls to the same low level as that achieved by castration. Because the initial flare in testosterone may cause an acute enlargement of the cancer, *anti-androgens are given usually for the first two weeks following the first injection of the gonadorelin analogue.... gonadorelin analogue
a group of synthetic human insulins with specific alterations in their amino-acid sequences designed to modify their rate of absorption from the subcutaneous injection site. Some are absorbed more rapidly and have a shorter duration of action than conventional short-acting human insulin; others are absorbed more slowly at a more consistent rate than conventional medium-acting *isophane insulin to give a more sustained control of fasting and premeal blood glucose levels and therefore a reduced risk of *hypoglycaemia. These analogues include the short-acting insulin aspart, insulin glulisine, and insulin lispro; the long-acting insulin detemir and insulin glargine; and the ultra-long-acting insulin degludec.... insulin analogues